Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP)

PHASE3RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 24, 2019

Primary Completion Date

July 31, 2026

Study Completion Date

January 31, 2028

Conditions
Multiple Sclerosis
Interventions
OTHER

DMT withdrawal

Group 1 (DMT withdrawal) will not undergo any disease modifying treatments (DMT).

DRUG

DMT continuation

Group 2 (DMT continuation) may undergo the DMT . The therapy continued in this research is the one previously established, at the same dose, not implying additional precautions for use.

Trial Locations (27)

Unknown

RECRUITING

CHU Angers, Angers

ACTIVE_NOT_RECRUITING

CHU de Bordeaux, Bordeaux

RECRUITING

CHU Brest, Brest

ACTIVE_NOT_RECRUITING

CH de Chartres, Chartres

RECRUITING

CHU Clermont-Ferrand, Clermont-Ferrand

ACTIVE_NOT_RECRUITING

Hôpital Henri Mondor, Créteil

ACTIVE_NOT_RECRUITING

CHU Dijon, Dijon

RECRUITING

CHU Grenoble, Grenoble

ACTIVE_NOT_RECRUITING

CH de Libourne, Libourne

RECRUITING

CHU Lille, Lille

RECRUITING

Hôpital Saint Vincent de Paul, Lille

RECRUITING

Hospices Civils Lyon, Lyon

ACTIVE_NOT_RECRUITING

AP-HM, Marseille

RECRUITING

CHU Montpellier, Montpellier

TERMINATED

CHU Nancy, Nancy

RECRUITING

CHU Nantes, Nantes

RECRUITING

CHU Nice, Nice

NOT_YET_RECRUITING

CHU de Nîmes, Nîmes

RECRUITING

AP-HP (La Pitié Salpêtrière), Paris

TERMINATED

Fondation de Rothschild, Paris

RECRUITING

CH Poissy, Poissy

TERMINATED

CHU Poitiers, Poitiers

RECRUITING

CH Quimper, Quimper

RECRUITING

CHU Rennes, Rennes

RECRUITING

CHU Strasbourg, Strasbourg

ACTIVE_NOT_RECRUITING

CH de Foch, Suresnes

RECRUITING

CHU Tours, Tours

All Listed Sponsors
lead

Rennes University Hospital

OTHER